InvestorsHub Logo
Followers 0
Posts 7389
Boards Moderated 0
Alias Born 08/03/2012

Re: retiredanalyst post# 71589

Friday, 06/09/2017 12:25:25 PM

Friday, June 09, 2017 12:25:25 PM

Post# of 207156
I disagree and here's why. If you are going to jump in a biopharma play pending FDA approval of phase 3 trials, guess what, you'd be late to the party after they approved it. The real reward is getting in before we get official confirmation impacting the valuation. Similarly with DOLV, if you wait for the financials and every element to be chewed for you, you'll be buying in at $2.00+. The real reward is doing the DD, realistically anticipating the outcome, and getting in before it happens.

If you disagree, please come back once the ticker has changed, consolidated fins are published and multiple PRs are released. See you at $2.00+